【參考文獻】
1 Chlebowski RT,Kuller LH,Prentice RL,et al.Breast cancer after use of estrogen plus progestin in postmenopausal women.N Engl J Med,2009,360:573587.
2 Chevallier B,Heintzmann F,Mosseri V,et al.Prognostic value of estrogen and progesterone receptors in operable breast cancer. Results of a univariate and multivariate analysis.Cancer, 1988,62:25172524.
3 Gnant M,Mlineritsch B,Schippinger W,et al.Endocrine therapy plus zoledronic acid in premenopausal breast cancer.N Engl J Med,2009,360:679691.
4 Shippinger W,Regitnig P,Dandachi N,et al.Evaluation of the prognostic significance of androgen receptor expression in metastatic breast cancer.Virchows Arch,2006,449:2430.
5 Carreno G, Del Casar JM, Corte MD, et al. Local recurrence after mastectomy for breast cancer:analysis of clinicopathological, biological and prognostic charactersitics. Breast Cancer Res Treat,2006,6:4348.
6 Allegra JC,Woodcock T,Woolf S,et al.A randomized trial comparing mitoxantrone with doxorubicin in patients with stage Ⅳ breast cancer. Invest New Drugs,1985,3:153161.
7 Kumar R, Johnson BH, Thampson EB. Overview of the structural basis for transcription regulation by nuclear hormone receptors.Essays Biochem,2004,40:2739醫(yī).學全.在.線網(wǎng)站jfsoft.net.cn.
8 Ogawa Y,Hai E,Matsumoto K,et al. Androgen receptor expression in breast cancer:relationship with clinicopathological factors and biomarkers. Int J Clin Oncol,2008,13:431435.
9 Moinfar F,Okcu M,Tsybrovskyy O, et al. Androgen receptors frequently are expressed in breast carcinomas potential relevance to new therapeutic strategies. Cancer, 2003,98: 703711.
10 Agrawal A K,Jilen M, Grzebieniak Z,et al.Androgen receptors as a prognostic and predictive factor in breast cancer.Folia Histochem Cytobiol, 2008,46:269276.